One Step Up in Antiproliferative Activity: The Ru-Zn Complex [RuCp(PPh3)2-μ-dmoPTA-1κP:2κ2N,N′-ZnCl2](CF3SO3)

被引:11
作者
Mendoza, Zenaida [1 ]
Lorenzo-Luis, Pablo [1 ]
Scalambra, Franco [2 ]
Padron, Jose M. [3 ]
Romerosa, Antonio [2 ]
机构
[1] Univ La Laguna LL, Dept Quim Secc Quim Inorgan, San Cristobal la Laguna 38206, Spain
[2] Univ Almeria, Area Quim Inorgan, CIESOL, Carretera Sacramento S-N, Almeria, Spain
[3] Univ La Laguna, IUBO AG, BioLab, C Astrofis Francisco Sanchez 2, San Cristobal la Laguna 38206, Spain
关键词
Antiproliferation; Cancer; Heterometallic complexes; PTA derivatives; Ruthenium; ARENE-RUTHENIUM(II) COMPLEXES; RUTHENIUM COMPLEXES; ANTICANCER; ACTIVATION; LIGANDS; DMOPTA; ZINC;
D O I
10.1002/ejic.201800857
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The synthesis, characterization and antiproliferative activity of the bimetallic Ru-Zn complex [RuCp(PPh3)(2)-mu-dmoPTA-1 kappa P:2 kappa N-2,N '-ZnCl2](CF3SO3) (4) and the monometallic Ru complex [RuCp(PPh3)(2)(dmoPTA-1 kappa P)](CF3SO3) (5) are presented. Against human lung, cervix, breast, and colon solid tumor cell lines, complex 4 showed an enhanced antiproliferative activity (GI(50) = 30-83 nm) when compared to its parent complex [RuCp(PPh3)(2)(HdmoPTA-1 kappa P)](CF3SO3) (2). Additionally, it was significantly more active against the breast cancer cell line T-47D than its sibling cobalt complex [RuCp(PPh3)(2)-mu-dmoPTA-1 kappa P:2 kappa N-2,N '-CoCl2](CF3SO3) (3). When evaluated against non-tumor human cell line BJ-hTert, complex 4 was 3-8 times less active, indicating a large selectivity for tumor cells, while compound 5 was not selective.
引用
收藏
页码:4684 / 4688
页数:5
相关论文
共 36 条
[1]   Synthesis, catalytic properties and biological activity of new water soluble ruthenium cyclopentadienyl PTA complexes [(C5R5)RuCl(PTA)2] (R = H, Me; PTA=1,3,5-triaza-7-phosphaadamantane) [J].
Akbayeva, DN ;
Gonsalvi, L ;
Oberhauser, W ;
Peruzzini, M ;
Vizza, F ;
Brüggeller, P ;
Romerosa, A ;
Sava, G ;
Bergamo, A .
CHEMICAL COMMUNICATIONS, 2003, (02) :264-265
[2]   Metal Anticancer Complexes - Activity, Mechanism of Action, Future Perspectives [J].
Alessio, Enzo ;
Guo, Zijian .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) :1539-1540
[3]   Thirty Years of the Drug Candidate NAMI-A and the Myths in the Field of Ruthenium Anticancer Compounds: A Personal Perspective [J].
Alessio, Enzo .
EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2017, (12) :1549-1560
[4]   Organometallic ruthenium-based antitumor compounds with novel modes of action [J].
Ang, Wee Han ;
Casini, Angela ;
Sava, Gianni ;
Dyson, Paul J. .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2011, 696 (05) :989-998
[5]   Ruthenium metallopharmaceuticals [J].
Clarke, MJ .
COORDINATION CHEMISTRY REVIEWS, 2002, 232 (1-2) :69-93
[6]   Methyl-cyclopentadienyl Ruthenium Compounds with 2,2′-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential [J].
Corte-Real, Leonor ;
Teixeira, Ricardo G. ;
Girio, Patricia ;
Comsa, Elisabeta ;
Moreno, Alexis ;
Nasr, Rachad ;
Baubichon-Cortay, Helene ;
Avecilla, Fernando ;
Marques, Fernanda ;
Paula Robalo, M. ;
Mendes, Paulo ;
Prates Ramalho, Joao P. ;
Helena Garcia, M. ;
Falson, Pierre ;
Valente, Andreia .
INORGANIC CHEMISTRY, 2018, 57 (08) :4629-4639
[7]   Haloalkane C-X bond activation by a ruthenium(II) complex:: X-ray characterization of a ruthenium(III) intermediate species in the atom transfer radical polymerization of methyl methacrylate [J].
del Río, I ;
van Koten, G ;
Lutz, M ;
Spek, AL .
ORGANOMETALLICS, 2000, 19 (03) :361-364
[8]  
Dhawan DK, 2010, INDIAN J MED RES, V132, P676
[9]   OLEX2: a complete structure solution, refinement and analysis program [J].
Dolomanov, Oleg V. ;
Bourhis, Luc J. ;
Gildea, Richard J. ;
Howard, Judith A. K. ;
Puschmann, Horst .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 2009, 42 :339-341
[10]   The role of zinc in life: A review [J].
Frassinetti, Stefania ;
Bronzetti, Giorgio ;
Caltavuturo, Leonardo ;
Cini, Marco ;
Della Croce, Clara .
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2006, 25 (03) :597-610